Deciphera Pharmaceuticals (DCPH) Tops Q2 EPS by 5c

Deciphera Pharmaceuticals (NASDAQ: DCPH) reported Q2 EPS of ($0.57), $0.05 better than the analyst estimate of ($0.62). Revenue for the quarter came in at $38.3 million versus the consensus estimate of $36.1 million.

For earnings history and earnings-related data on Deciphera Pharmaceuticals (DCPH) click here.

You May Also Be Interested In

• Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
• Revelation Biosciences (REVB) Misses Q2 EPS by 4c
• Array Digital Infrastructure, Inc. (AD) Tops Q2 EPS by 345c